GlaxoSmithKline (GSK) is one of the biggest names in the Pharmaceutical Market of Pakistan. It would not be wrong to say that GSK is the Market Leader among the top Multinational Corporations in Pakistan, as well all other national pharmaceutical companies.
GSK began operating from UK in 1880, by the name of Wellcome and Company. Glaxo was later formed in 1904. Originally, Glaxo was a baby food manufacturer, processing the baby milk and marketing it by the same name.
In 2001, Glaxo Welcome and Smithkline and French, Beecham Pakistan, merged to form GlaxoSmithKline (GSK) becoming the largest Pharmaceutical Company in Pakistan. There it launched a Central Nervous System (CNS) Franchise, to combat depression, which affected 33% of Pakistani population.
In 2002, GSK launched ‘Seretide’ a block buster drug to fight asthma, a disease that effects 300 million people worldwide. ‘Augmentin’ became the first ever drug in Pakistan, to cross the Rs. 1 Billion mark.
Providing protection to sensitive teeth, GSK Pakistan begins to locally manufacture ‘Sensodyne’ in 2004, the number 1 tooth paste in the sensitivity worldwide.
In 2005, Pakistan was struck with a massive Earth quake. GSK immediately responded to the earth quake relief efforts by contributing Rs. 400 million and life saving medicines worth Rs. 20 million within 48 hours of the earth quake. Same year, GSK received; Excellence Award in Best Practices’ by the Occupational, Health and Safety by Employers Federation of Pakistan.
In 2006, GSK achieved a big miles stone, of launching ‘Rotarix’. This vaccine was designed to combat Rotavirus, the leading cause of severe diarrhea in children. This was the only and first of its kid of vaccine available in Pakistan. In the same year GSK received 50star rating from the Global Internal Audit, the highest rating in the industry. Same year, GSKs site in West Wharf completed its 1 million hours without any injury/illness. As one of the multinational companies in Pakistan, it really gained a lot recognition.
In 2007, reaffirming its commitment towards the Pakistani market, GSK added a 77,000 sq/ft state of the art Penicillin manufacturing site. Since the minimum requirement for infrastructure by multinational companies in Pakistan is about 60,000 sq ft of area. GSK received ‘The Most Preferred Pharmaceutical Company’ award by the Pakistan Society for Human Resource Management.
GSK Pakistan supplies 71 million of doses of vaccines, the largest shipment in the history of GSK Biological, to the Pakistan Government for Expanded Program on Immunization (EPI). Gsk received the Excellence award for best management practices by the Management Association of Pakistan.
Another merger of Stiefel Laboratories and Bristol Mayers Squib business in Pakistan took places in 2009. GSK won the Annual Environment Excellence Award in recognition of it polices on safeguarding health.
In 2010, ‘Augmentin’ crosses the Rs 3 Billion mark, in the history of pharmaceutical market. Cervex a cancer vaccine was launched, as a sign of GSKs commitment towards eradicating cancer in women.
In 2011, Panadol entered the club of billionaire, by crossing the Rs. 1 billon mark. It became the fourth GSK brand to in the Pakistani market.
At present GSK has a Market share of around 15%. After about 12 years of enabling people to do more, feel better and live longer, GSK Pakistan stands as the largest Pharmaceutical Company in Pakistan and leading the industry operation and competition among the MNCs in Pakistan by volume, value and prescription.